 EDEN PRAIRIE, Minn., Oct. 05, 2022 GLOBE NEWSWIRE -- Miromatrix Medical Inc. NASDAQ: MIRO, a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients lives, today announced that CEO Jeff Ross will present at the 2022 Cell Gene Meeting on the Mesa. The three day event held this year on October 11-13 features in-person and pre-recorded virtual presentations by leading public and private companies highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and regenerative medicine. 